Aims & Scope – Drug Delivery Letters

ISSN (Print): 2210-3031
ISSN (Online): 2210-304X

Latest Issue: Volume 12 , Issue 2 , 2022

Aims & Scope

Drug Delivery Letters publishes short papers and mini-reviews in all important aspects of drug delivery, gene delivery, and drug targeting. Short papers report seminal results and research approaching conclusion of importance in the field.

The journals’ scope covers all the basic and applied research in drug delivery and targeting at molecular and cellular levels and novel delivery systems. The manuscript submission process is fully electronic to ensure rapid publication of research results. Read now: https://bit.ly/3CSEB62

Aims & Scope – Infectious Disorders – Drug Targets

(Formerly Current Drug Targets – Infectious Disorders) 

ISSN (Print): 1871-5265
ISSN (Online): 2212-3989

Aims & Scope

Infectious Disorders – Drug Targets aims to cover all the latest and outstanding developments in medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in infectious disorders e.g. disease specific proteins, receptors, enzymes, genes. Each issue of the journal contains a series of timely in-depth reviews and research articles written by leaders in the field covering a range of current topics on drug targets involved in infectious disorders. As the discovery, identification, characterization and validation of novel human drug targets for anti-infective drug discovery continue to grow, this journal will be essential reading for all pharmaceutical scientists involved in drug design, discovery and development. All aspects related to viral or bacterial diseases including HIV, AIDS and other sexually transmitted diseases (STDs) are also included in the scope of the journal. Read now: https://bit.ly/3cxJNS2

New Issue | Current Neuropharmacology ; Volume 18 Issue 2

 

AIMS & SCOPE

Current Neuropharmacology aims to provide current, comprehensive/mini reviews and guest edited issues of all areas of neuropharmacology and related matters of neuroscience. The reviews cover the fields of molecular, cellular, and systems/behavioural aspects of neuropharmacology and neuroscience.

The journal serves as a comprehensive, multidisciplinary expert forum for neuropharmacologists and neuroscientists.

 

Articles from the journal: Current Neuropharmacology; Volume 18 Issue 2

• The “Entourage Effect”: Terpenes Coupled with Cannabinoids for the Treatment of Mood Disorders and Anxiety Disorders
• The Endocannabinoid System May Modulate Sleep Disorders in Aging
• Trigeminal Neuralgia: Basic and Clinical Aspects
• The Cold Case of Metabotropic Glutamate Receptor 6: Unjust Detention in the Retina?
• Amphetamine Use in the Elderly: A Systematic Review of the Literature
• Modeling Neuronal Diseases in Zebrafish in the Era of CRISPR
• Epigenetic Effects Mediated by Antiepileptic Drugs and their Potential Application

For details on the articles, please visit this link: http://www.eurekaselect.com/node/603/current-neuropharmacology/issue/18/2718/2/9592

Call for Papers | Current Pharmaceutical Design

Special Thematic Issues | Forthcoming Issues

Journal: Current Pharmaceutical Design

 

Guest Editor(s): Celestino Sardu
Tentative Publication Date: January, 2020

 

“Metabolic Syndrome impact on molecular, and cellular functions in patients affected by heart failure: therapeutic, diagnostic and clinical applications”

 

In this Special Issue we would try to bring the two major diseases together by focusing on common molecular pathways, mechanisms and subsequently on clinical outcomes. We may speculate that, the identification of mechanisms underlying the pathophysiology of MS and its CV complications may represent an area of significant research efforts, attracting scientists and clinicians from a diverse range of fields including biochemistry, pharmacology, internal medicine, cardiology and geriatrics among several others.Our Special Issue hypothesis is that, the final goal in the near future will be to find treatments better tailored to MS patients with HF using a personalized–medicine approach. Therefore, here we invite investigators to submit to this Special Issue both original research articles, clinical trials and reviews having the purpose to address novel diagnostic tools or new therapeutic treatments for MS and HF. For more details please visit: https://benthamscience.com/journal-files/special-issue-details/CPD-SII20181228-01.pdf

 

To submit your paper, email at: hermain@benthamscience.net and CC: faizan@benthamscience.net

Become a Reviewer | Current Alzheimer Research (CAR)

 

Current Alzheimer Research publishes peer-reviewed frontier review, research, drug clinical trial studies and letter articles on all areas of Alzheimer’s disease. This multidisciplinary journal will help in understanding the neurobiology, genetics, pathogenesis, and treatment strategies of Alzheimer’s disease. The journal publishes objective reviews written by experts and leaders actively engaged in research using cellular, molecular, and animal models. The journal also covers original articles on recent research in fast emerging areas of molecular diagnostics, brain imaging, drug development and discovery, and clinical aspects of Alzheimer’s disease. Manuscripts are encouraged that relate to the synergistic mechanism of Alzheimer’s disease with other dementia and neurodegenerative disorders. Book reviews, meeting reports and letters-to-the-editor are also published. The journal is essential reading for researchers, educators and physicians with interest in age-related dementia and Alzheimer’s disease. Current Alzheimer Research provides a comprehensive ‘bird’s-eye view’ of the current state of Alzheimer’s research for neuroscientists, clinicians, health science planners, granting, caregivers and families of this devastating disease.

 

Abstracted and Indexed in:

• Science Citation Index-Expanded
• Journal Citation Reports/Science Edition
• InCites
• Neuroscience Citation Index
• Current Contents® – Life Sciences
• Current Contents® – Clinical Medicine
• BIOSIS
• BIOSIS Previews
• BIOSIS Reviews Reports and Meetings
• MEDLINE/PubMed/Index Medicus
• Scopus
• EMBASE
• Chemical Abstracts Service/SciFinder
• PsycINFO
• ProQuest
• ChemWeb
• Google Scholar
• BIOBASE
• EMNursing
• EMCare
• Alzforum
• MediaFinder®-Standard Periodical Directory
• Genamics JournalSeek
• PubsHub
• Index Copernicus
• J-Gate
• CNKI Scholar
• Suweco CZ
• TOC Premier
• EBSCO
• British Library
• Ulrich’s Periodicals Directory
• JournalTOCs

 

The Journal is interested in appointing active Reviewers on the Journal’s Board. If you are working in the mentioned field of the journal and are interested in becoming a Reviewer, send us your CV at the below mentioned email. If, however, the scope of the journal is not directly related to your field of interest then please feel free to recommend suitable colleagues for the Reviewers of the journal and, if possible, send us their CV mentioning the field of interest.

 

Please submit the CV at your earliest convenience at hermain@benthamscience.netand CC faizan@benthamscience.net, mentioning in the subject line your field of interest. The responsibilities of Reviewers will be discussed in detail further once the CV is received.

 

Become an Editorial Board Member (EBM) | Current Alzheimer Research (CAR)

 

Current Alzheimer Research publishes peer-reviewed frontier review, research, drug clinical trial studies and letter articles on all areas of Alzheimer’s disease. This multidisciplinary journal will help in understanding the neurobiology, genetics, pathogenesis, and treatment strategies of Alzheimer’s disease. The journal publishes objective reviews written by experts and leaders actively engaged in research using cellular, molecular, and animal models. The journal also covers original articles on recent research in fast emerging areas of molecular diagnostics, brain imaging, drug development and discovery, and clinical aspects of Alzheimer’s disease. Manuscripts are encouraged that relate to the synergistic mechanism of Alzheimer’s disease with other dementia and neurodegenerative disorders. Book reviews, meeting reports and letters-to-the-editor are also published. The journal is essential reading for researchers, educators and physicians with interest in age-related dementia and Alzheimer’s disease. Current Alzheimer Research provides a comprehensive ‘bird’s-eye view’ of the current state of Alzheimer’s research for neuroscientists, clinicians, health science planners, granting, caregivers and families of this devastating disease.

 

Abstracted and Indexed in:

• Science Citation Index-Expanded
• Journal Citation Reports/Science Edition
• InCites
• Neuroscience Citation Index
• Current Contents® – Life Sciences
• Current Contents® – Clinical Medicine
• BIOSIS
• BIOSIS Previews
• BIOSIS Reviews Reports and Meetings
• MEDLINE/PubMed/Index Medicus
• Scopus
• EMBASE
• Chemical Abstracts Service/SciFinder
• PsycINFO
• ProQuest
• ChemWeb
• Google Scholar
• BIOBASE
• EMNursing
• EMCare
• Alzforum
• MediaFinder®-Standard Periodical Directory
• Genamics JournalSeek
• PubsHub
• Index Copernicus
• J-Gate
• CNKI Scholar
• Suweco CZ
• TOC Premier
• EBSCO
• British Library
• Ulrich’s Periodicals Directory
• JournalTOCs

 

The Journal is interested in appointing active Editorial Board Members on the Journal’s Board. If you are working in the mentioned field of the journal and are interested in becoming an Editorial Board Member, please send us your CV and a list of publications to the email mentioned below. If, however, the scope of the journal is not directly related to your field of interest then please feel free to recommend suitable colleagues for the Editorial Board membership of the journal and, if possible, send us their CV along with their list of publications.

 

Please submit the CV at your earliest convenience at hermain@benthamscience.netand CC faizan@benthamscience.net, mentioning in the subject line your field of interest. The responsibilities of Editorial Board Members will be discussed in detail further once the CV is received.

 

Aims & Scope – Current Neurovascular Research

Aims & Scope:

 

Current Neurovascular Research provides a cross platform for the publication of scientifically rigorous research that addresses disease mechanisms of both neuronal and vascular origins in neuroscience. The journal serves as an international forum publishing novel and original work as well as timely neuroscience research reviews in the disciplines of cell developmental disorders, plasticity, and degeneration that bridges the gap between basic science research and clinical discovery. Current Neurovascular Research emphasizes the elucidation of disease mechanisms, both cellular and molecular, which can impact the development of unique therapeutic strategies for neuronal and vascular disorders.

 

For more details, please visit: https://benthamscience.com/journals/current-neurovascular-research/aims-scope/#top

Recently Published Issue of the Journal Current Alzheimer Research

Current Alzheimer Research publishes peer-reviewed frontier review, research and letter articles on all areas of Alzheimer’s disease. This multidisciplinary journal will help in understanding the neurobiology, genetics, pathogenesis, and treatment strategies of Alzheimer’s disease. The journal publishes objective reviews written by experts and leaders actively engaged in research using cellular, molecular, and animal models. The journal also covers original articles on recent research in fast emerging areas of molecular diagnostics, brain imaging, drug development and discovery, and clinical aspects of Alzheimer’s disease.

Following are the articles from the recent issue of the journal Current Alzheimer Research, 12 Issue 1:

Article: The Contribution of Proteinase-Activated Receptors to Intracellular Signaling, Transcellular Transport and Autophagy in Alzheimer´s Disease

Author(s): Radoslav Matej, Zdenek Rohan, Karel Holada and Tomas Olejar

 

Article: Beneficial Effects of the β-Secretase Inhibitor GRL-8234 in 5XFAD Alzheimer’s Transgenic Mice Lessen During Disease Progression

Author(s): Latha Devi, Jordan Tang and Masuo Ohno

 

Article: Acute Oral Bryostatin-1 Administration Improves Learning Deficits in the APP/PS1 Transgenic Mouse Model of Alzheimer’s Disease

Author(s): L.M. Schrott, K. Jackson, P. Yi, F. Dietz, G.S. Johnson, T.F. Basting, G. Purdum, T. Tyler, J.D. Rios, T.P. Castor and J.S. Alexander

 

Article: Amyloid-Beta Protein Clearance and Degradation (ABCD) Pathways and their Role in Alzheimer’s Disease          

Author(s): Robert J. Baranello, Krishna L. Bharani, Vasudevaraju Padmaraju, Nipun Chopra, Debomoy K. Lahiri, Nigel H. Greig, Miguel A. Pappolla and Kumar Sambamurti

 

Article: No Significant Effect of 7,8-Dihydroxyflavone on APP Processing and Alzheimer-Associated Phenotypes

Author(s): Weitao Zhou, Xiaoyong Li, Daochao Huang, Weihui Zhou, Tingyu Li and Weihong Song

 

Article: Evaluating High-Dose Rivastigmine Patch in Severe Alzheimer’s Disease: Analyses with Concomitant Memantine Usage as a Factor

Author(s): George T. Grossberg, Martin R. Farlow, Xiangyi Meng and Drew M. Velting

 

Article: Expanded Temporal Binding Windows in People with Mild Cognitive Impairment

Author(s): Jason S. Chan, Jochen Kaiser, Mareike Brandl, Silke Matura, David Prvulovic, Michael J. Hogan and Marcus J. Naumer

 

Article: Predicting Progression from Cognitive Impairment to Alzheimer’s Disease with the Disease State Index

Author(s): Anette Hall, Jussi Mattila, Juha Koikkalainen, Jyrki Lotjonen, Robin Wolz, Philip Scheltens, Giovanni Frisoni, Magdalini Tsolaki, Flavio Nobili, Yvonne Freund-Levi, Lennart Minthon, Lutz Frolich, Harald Hampel, Pieter Jelle Visser and Hilkka Soininen

 

Article: Examination of Hippocampal Differences Between Alzheimer Disease, Amnestic Mild Cognitive Impairment and Normal Aging: Diffusion Kurtosis

Author(s): Dan Wang, Zhao-Hui Guo, Xing-Han Liu, Yue-Hua Li and He Wang

Article: Associations between Alzheimer’s Disease and Blood Homocysteine, Vitamin B12, and Folate: A Case-Control Study

Author(s): Hui Chen, Shuai Liu, Lu Ji, Tianfeng Wu, Fei Ma, Yong Ji, Yuying Zhou, Miaoyan Zheng, Meilin Zhang and Guowei Huang

For details, please visit: http://bit.ly/1wZvWq1

Recent Issue of the Journal Current Alzheimer Research has been published

Current Alzheimer Research, 11 Issue 10

Aims & Scope

Current Alzheimer Research publishes peer-reviewed frontier review, research and letter articles on all areas of Alzheimer’s disease. This multidisciplinary journal will help in understanding the neurobiology, genetics, pathogenesis, and treatment strategies of Alzheimer’s disease. The journal publishes objective reviews written by experts and leaders actively engaged in research using cellular, molecular, and animal models. The journal also covers original articles on recent research in fast emerging areas of molecular diagnostics, brain imaging, drug development and discovery, and clinical aspects of Alzheimer’s disease.

http://www.eurekaselect.com/126454/issue/10

Abstracted & Indexed in:

MEDLINE/Index Medicus, Science Citation Index Expanded, Journal Citation Reports/Science Edition, Scopus, Neuroscience Citation Index, Current Contents®/Life Sciences, Current Contents®/Clinical Medicine, PsycINFO, Alzforum, EMNursing, EMBASE, EMCare, Chemical Abstracts, BIOSIS, BIOSIS Previews, BIOSIS Reviews Reports and Meetings, BIOBASE, MediaFinder®-Standard Periodical Directory, Genamics JournalSeek, PubsHub, J-Gate.

For more details please visit: http://benthamscience.com/journal/index.php?journalID=car